The 4th Annual Recombinant Antibodies Conference seeks to highlight the importance of monoclonal antibodies in the world of proteins. The Conference will showcase how industry leaders are answering challenges such as decreasing immunogenicity, improving cell line productivity and decreasing manufacturing costs.
"Jane Hughes and Ian Chessel will speak on the topic of ""IL-6 neutralisation reduces inflammatory pain in mouse models.""
MedImmune is a sponsor."
Added by MedImmune on January 13, 2011